InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: entdoc post# 102220

Sunday, 11/25/2012 8:51:40 PM

Sunday, November 25, 2012 8:51:40 PM

Post# of 346282
Entdoc, I see these retrospective studies to be supporting of the MOA Thorpe has put forth for the switching
of M2-type macrophages to M1-type, and that this could be a possible explanation for the increased survival
seen in the NSCLC and possibly pancreatic cancer trials. I expect this would apply to breast and prostate cancers also.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News